Literature DB >> 16411194

Complementary and alternative medicine in pediatric oncology: availability and institutional policies in Canada--a report from the Children's Oncology Group.

Donna L Johnston1, Kim Nagel, Claire O'Halloran, Susan F Sencer, Kara M Kelly, Sarah Friebert, Joanne M Hilden, Debra L Friedman.   

Abstract

Complementary and alternative medicine (CAM) is used frequently by pediatric oncology patients. A survey exploring the institutional practices and policies surrounding CAM use in pediatric oncology patients was completed by 17 pediatric hematology/oncology centers in Canada. We found that CAM was offered in only 18% of the institutions, but 94% of the communities. Only 6% of oncology divisions made direct referrals to community CAM providers, and only 20% of the centers had policies regarding use of CAM therapies for their patients. Despite published widespread use of CAM therapies, our study demonstrates that institutional CAM resources and policies on CAM are present in much lower proportions.

Entities:  

Mesh:

Year:  2006        PMID: 16411194     DOI: 10.1002/pbc.20772

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Perceptions about complementary and alternative medicine use among Chinese immigrant parents of children with cancer.

Authors:  Lisa Watt; Sonia Gulati; Nicola T Shaw; Lillian Sung; David Dix; Iraj Poureslami; Anne F Klassen
Journal:  Support Care Cancer       Date:  2011-02-12       Impact factor: 3.603

2.  Naturopathic Oncology Care for Pediatric Cancers: A Practice Survey.

Authors:  Athanasios Psihogios; Jullie K Ennis; Dugald Seely
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 3.  Plant toxins and acute medicinal plant poisoning in children: A systematic literature review.

Authors:  Adel Ghorani-Azam; Samaneh Sepahi; Bamdad Riahi-Zanjani; Anahita Alizadeh Ghamsari; Seyed Ahmad Mohajeri; Mahdi Balali-Mood
Journal:  J Res Med Sci       Date:  2018-03-27       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.